SQZ Biotechnologies Company
SQZB
$0.028
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 7.84% | 8.90% | -2.33% | -15.60% | -4.32% |
| Total Depreciation and Amortization | 4.06% | 5.52% | 9.13% | 5.93% | -0.80% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 16.53% | -37.38% | -19.91% | -0.89% | 18.86% |
| Change in Net Operating Assets | 5.55% | -11.14% | -8.70% | 26.51% | -6.42% |
| Cash from Operations | 11.31% | 1.38% | -5.98% | -1.72% | -4.30% |
| Capital Expenditure | 49.41% | 18.50% | 39.56% | 14.85% | 42.80% |
| Sale of Property, Plant, and Equipment | 400.00% | 355.88% | -100.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 88.89% | 53.28% | 35.89% | 20.39% | -105.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -92.08% | -72.81% | 268.77% | -92.68% | -96.87% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | -92.08% | -72.81% | 690.23% | -92.43% | -96.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 7.46% | -1.69% | -1.25% | -197.29% | -239.90% |